Copyright
©The Author(s) 2025.
World J Exp Med. Mar 20, 2025; 15(1): 100275
Published online Mar 20, 2025. doi: 10.5493/wjem.v15.i1.100275
Published online Mar 20, 2025. doi: 10.5493/wjem.v15.i1.100275
Table 1 Pharmacological effects of curcumin
Pharmacological activity | Mechanisms/effects | Key points |
Anti-inflammatory properties | Inhibition of NF-κB activation and suppression of inflammatory mediators; suppression of COX-2, LOX, and iNOS expression; modulation of pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6); regulation of MAPK signaling pathways; inhibition of inflammatory transcription factors | Modulates gut microbiota |
Antioxidant activities | Direct scavenging of free radicals; enhancement of cellular antioxidant defenses; upregulation of Nrf2 pathway; increase in antioxidant enzyme activities (SOD, CAT, GPx); metal ion chelation | Protects against oxidative stress-induced cellular damage |
Anticancer properties | Cell cycle arrest and induction of apoptosis; Inhibition of cancer cell proliferation; modulation of microRNAs; suppression of angiogenesis; regulation of cancer stem cells; interference with signaling pathways (STAT3, Wnt/β-catenin, PI3K/Akt) | Gut microbiota interaction enhances effects |
Immunomodulatory effects | Regulation of T cell differentiation and function; influence on B cell response; modulation of macrophage polarization; modification of dendritic cell function; alteration of natural killer cell activity | Significant impact on gut immunity |
Neuroprotective activities | Protection of the blood-brain barrier; reduction of neuroinflammation; prevention of protein aggregation; enhancement of neuroplasticity; modulation of neurotransmitter systems | Gut-brain axis plays a crucial role |
Cardiovascular protection | Improvement of endothelial function; reduction of atherosclerosis; modulation of lipid metabolism; prevention of cardiac hypertrophy; protection against ischemia-reperfusion injury | |
Antidiabetic effects | Enhancement of insulin sensitivity; protection of β-cell function; regulation of glucose metabolism; reduction of advanced glycation end-products; amelioration of diabetic complications | Ameliorates diabetic complications |
Hepatoprotective activities | Prevention of hepatic fibrosis; protection against drug-induced liver injury; reduction of hepatic steatosis; modulation of liver enzyme activities; enhancement of hepatic regeneration | |
Antimicrobial properties | Broad-spectrum activity against bacterial, fungal, viral, and parasitic infections | Involves modulation of gut microbiota |
Table 2 Altered bacterial species in the gut due to curcumin
Bacterial species altered | Ref. |
Escherichia-Shigella, Lachnoclostridium, Lactobacillaceae spp. | [27] |
Clostridium, Bacteroides, Parabacteroides, Collinsella, Kluyvera, Enterococcus spp., Blautia spp., Ruminococcus spp. | [7] |
Butyrate-producing bacteria, Clostridium, Bacteroides spp., Beneficial gut microbiota | [17] |
Blautia spp. MRG-PMF1 | [20] |
Lactobacilli, Clostridium perfringens, Anaerobic bacteria producing butyric acid | [18] |
Akkermansia, Firmicutes/Bacteroidetes ratio | [6] |
Table 3 Mechanisms of action of curcumin
Mechanism of action | Ref. |
Regulation of Th17/Treg balance | [30] |
Modulation of microbial diversity and abundance | [30] |
Improvement of gut microbiota composition | [30] |
Influence on immune modulation | [29,50] |
Restoration of gut flora balance | [17,29,34,35,50] |
Enhancement of cytarabine response in acute myeloid leukemia | [36] |
Indirect influence on neuroprotection through modulation of signaling pathways | [28,32] |
Modulation of intestinal barrier function | [31] |
Biotransformation by gut microbiota | [20,33,35] |
Table 4 Implications of gut microbiome in gastrointestinal disorders
Gastrointestinal disorder | Curcumin's effects | Mechanisms of action | Clinical implications |
Inflammatory bowel disease | Ulcerative colitis. Reduces disease activity index and endoscopic scores. Increases beneficial bacteria | NF-κB pathway inhibition; Modulates Th17/Treg balance through microbiota alterations; Improves barrier function | Efficacious as adjunct therapy with mesalamine |
Crohn's disease. Reduces inflammatory markers (TNF-α, IL-1β, IL-6). Strengthens epithelial barrier integrity | Modifies intestinal microbiota composition. Influences bacterial metabolite production | Shows promise in maintaining remission | |
Colorectal cancer | Suppresses growth of pro-carcinogenic bacteria. Enhances production of beneficial metabolites | Alters microbial diversity in colorectal cancer microenvironment; modulates bacterial enzyme activities related to carcinogenesis | Synergistic effects with conventional chemotherapy |
IBS | Reduces abdominal pain and bloating. Normalizes bowel habits | Modifies gut microbiota composition. Improves gut-brain axis signaling | Effects vary across IBS subtypes (IBS-D vs IBS-C) |
Celiac disease | Reduces intestinal inflammation | Modifies intestinal permeability. Influences microbiota adaptation to gluten-free diet | Potential role in managing non-responsive celiac disease |
Gastric Disorders | Helicobacter pylori infection. Modification of gastric microbiota | Direct antimicrobial effects. Enhancement of mucosal defense | Synergistic effects with standard triple therapy |
Gastric cancer. Influences Helicobacter pylori-associated dysbiosis. Affects cancer stem cell populations | Modulates inflammatory responses | Potential role in prevention and therapy | |
Small intestinal bacterial overgrowth | Reduces bacterial overgrowth | Modifies small intestinal microbiota composition. Improves intestinal motility | Alleviates small intestinal bacterial overgrowth-associated symptoms |
Radiation-induced enteritis | Reduces oxidative stress | Preserves beneficial microbiota. Modulates inflammatory response | Maintains intestinal barrier function |
Drug-induced gastrointestinal injury | Non-steroidal anti-inflammatory drugs-induced damage. Maintains microbial homeostasis | Protects against mucosal injury; Reduces oxidative stress | Enhances mucosal recovery |
Chemotherapy-induced mucositis. Preserves microbiota diversity. Reduces inflammatory damage | Supports mucosal healing | Improves treatment tolerance |
Table 5 Mechanism of action of gut microbiome in gastrointestinal disorders
Mechanisms of action | Description | Implications |
Direct effects on gut microbiota | Selective pressure on bacterial populations: Curcumin selectively inhibits harmful bacteria while promoting the growth of beneficial microbes | Helps restore a balanced gut microbiome |
Modification of Bacterial Metabolism: Alters metabolic pathways of gut bacteria, affecting their growth and activity | May reduce production of harmful bacterial metabolites | |
Influence on bacterial adhesion and biofilm formation: Disrupts bacterial adhesion to gut mucosa and inhibits biofilm formation | Reduces infection risk and persistence of pathogens | |
Effects on bacterial virulence factors: Curcumin can suppress the expression of bacterial virulence factors | Lowers pathogenicity of harmful bacterial strains | |
Host-microbiota interactions | Modulation of immune responses: Modulates gut-associated immune cells, reducing excessive inflammatory responses | Helps in managing inflammatory bowel conditions |
Enhancement of barrier function: Strengthens the intestinal epithelial barrier, preventing translocation of pathogens | Prevents gut permeability ("leaky gut") | |
Regulation of mucus production: Promotes mucus secretion in the gut, aiding in the protection of the mucosal lining | Provides an additional layer of defense against pathogens | |
Influence on enterocyte function: Enhances the function of enterocytes, the absorptive cells of the intestinal lining | Improves nutrient absorption and gut health | |
Metabolic effects | Alteration of short-chain fatty acid production: Modulates the production of short-chain fatty acids like butyrate. | Supports gut barrier integrity and reduces inflammation |
Modification of bile acid metabolism: affects the synthesis and transformation of bile acids, impacting digestion and gut health | May alter gut microbial composition and metabolism | |
Influence on tryptophan metabolism: Modifies tryptophan metabolism, affecting serotonin production and gut-brain axis signaling | Potentially improves gut-brain communication and mood | |
Effects on bacterial enzyme activities: Alters the activities of bacterial enzymes involved in various metabolic processes | Influences gut homeostasis and metabolic health |
- Citation: Balaji S, Jeyaraman N, Jeyaraman M, Ramasubramanian S, Muthu S, Santos GS, da Fonseca LF, Lana JF. Impact of curcumin on gut microbiome. World J Exp Med 2025; 15(1): 100275
- URL: https://www.wjgnet.com/2220-315x/full/v15/i1/100275.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i1.100275